The 20 Best Hereditary Retinoblastoma Doctors Near Me in New York, NY

David Abramson is an Oncologist practicing medicine in New York, New York. Dr. Abramson is rated as an Elite provider by MediFind in the treatment of Hereditary Retinoblastoma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Retinoblastoma, Hereditary Retinoblastoma, Melanoma of the Eye, Vitrectomy, and Leg or Foot Amputation. Dr. Abramson is currently accepting new patients.

Jasmine Francis is an Oncologist practicing medicine in New York, New York. Dr. Francis is rated as a Distinguished provider by MediFind in the treatment of Hereditary Retinoblastoma. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Retinoblastoma, Melanoma of the Eye, Metastatic Uveal Melanoma, Vitrectomy, and Liver Embolization. Dr. Francis is currently accepting new patients.

Dr. Paul T. Finger has collected or discovered the latest and most advanced medical technologies for the diagnosis and treatment of ocular tumors and eye cancer.With great respect for collaboration, he works closely with you, your referring doctor and his associated specialists to provide the most excellent care possible.The New York Eye Cancer Center was designed to be a responsive and caring environment, we strive to be your and your doctor's first choice for eye cancer care.Dr. Finger is the Director of Ocular Tumor Services at the Manhattan Eye, Ear and Throat Hospital and teaches residents from the New York University School of Medicine.A world-recognized expert in radiation and surgical techniques to conserve the eye and vision; Dr. Finger has pioneered the use of palladium-103 plaque radiation for choroidal melanoma, 3D and high-frequency ultrasound to image intraocular tumors, and created this world-renowned web site. Dr. Finger publishes in the major clinical journals and lectures frequently at local, national and international meetings. He graduated from Tulane Medical School, the Manhattan Eye, Ear and Throat Hospital, and then completed specialty training in treatment of ocular tumors and orbital diseases.Dr. Finger is certified by the American Board of Ophthalmology and is a Fellow of both the American College of Surgeons and the American Academy of Ophthalmology and sees patients from all over the world.Dr Finger was a principal investigator for The Collaborative Ocular Melanoma Study. He Chaired the Ophthalmic Oncology Task Force that wrote the 2014 consensus guidelines for plaque radiationt therapy of choroidal melanoma and retinoblastoma for The American Brachytherapy Society. Dr. Finger was the clinical director for the Plaque Radiation Therapy (Task Group 129) of the American Association for Physicists in Medicine (AAPM). Dr. Finger is Chair of the Ophthalmic Oncology Task Group of The American Joint Committee on Cancer (AJCC) - International Union Against Cancer (UICC). The AJCC-UICC has created a universal language (TNM-classification) commonly used around the world to describe eye cancer.Dr. Finger has a particular interest in melanoma of the choroid, ciliary body and iris. He has written extensively about new ways to detect and treat retinoblastoma, conjunctival melanoma, squamous carcinoma, metastatic cancer to the eye and orbital tumors.Dr. Finger has assembled a team to care for patients with eye tumors. By picking the best doctors from several institutions, his team includes the top radiation, medical and pediatric oncologists from several institutions in New York City.Dr. Finger has spent his career inventing and improving new methods of diagnosis and treatment for eye cancer:. Dr. Finger is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Melanoma of the Eye, Metastatic Uveal Melanoma, Uveal Melanoma, Iridectomy, and Vitrectomy.

Brian Marr, MD heads the Ophthalmic Oncology Service at the Harkness Eye Institute. He has comprehensive experience in the diagnosis, treatment, and management of ocular tumors including intraocular tumor resection, laser, radiation, and chemotherapy procedures. He has helped devise thousands of complex treatments for tumors of the eye, eyelid, orbit, and conjunctiva for his adult, children, and infant patients. Currently, Dr. Marr is a collaborator on a Columbia University clinical trial for a first-of-its-kind, new class of drug treatment for uveal melanoma.Dr. Marr is a board-certified ophthalmologist whose work has centered around ophthalmic oncology since 2000. One of the very few ocular oncologists trained in all aspects of eye cancer, Dr. Marr's clinical experience in treating these diseases is among the most extensive in the United States. His interest and experience in ophthalmic oncology began during an eight-year tenure in the Ocular Oncology Service at the Wills Eye Hospital in Philadelphia. There, he gained extensive experience treating intraocular tumors, and tumors of the eyelid, orbit, and conjunctiva in children and adults. It was there that Dr. Marr developed and improved many surgical procedures used to cure cancers of the eye, successfully treated thousands of patients, and helped their families though their battle with eye cancer. Next, Dr. Marr moved on to Memorial Sloan Kettering Cancer Center, where he remain for nine years, starting in 2008.Dr. Marr has some of the greatest experience with intra-arterial chemotherapy for treating retinoblastoma in the country, if not the world, as well as all other forms of retinoblastoma treatment. He has been a key member of many multidisciplinary surgical teams, treating advanced skull base tumors and complex facial skin lesions. He has developed a strong belief and treatment philosophy that the best research be used to help his patients, rather than his best patients be used to help his research. The field of ophthalmic oncology encompasses many rare conditions and his experience helps his patients get the best care and results as quickly as possible. Dr. Marr lectures and consults across the US and abroad, and has authored numerous research articles in the field of ocular oncology. He is the principal investigator in a first-in-class drug study for treating primary uveal melanoma, in an international, multi-center trial. He also volunteers his medical expertise in underserviced parts of the world, such as Nigeria and Indonesia, and has helped train physicians in more than 20 countries. Dr. Marr’s efforts as a contributor to ongoing education in ocular oncology have been recognized by the American Academy of Ophthalmology, where he now serves as chief editor of the Academy’s Oncology and Pathology’s One network. Dr. Marr is rated as an Advanced provider by MediFind in the treatment of Hereditary Retinoblastoma. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Retinoblastoma, Melanoma of the Eye, Metastatic Uveal Melanoma, Uveal Melanoma, and Vitrectomy. Dr. Marr is board certified in Ophthalmology. Dr. Marr is currently accepting new patients.

Anita Price is a Pediatric Radiologist practicing medicine in New York, New York. Dr. Price is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. She is also highly rated in 28 other conditions, according to our data. Her clinical expertise encompasses Pleurisy, Pleural Effusion, WT1-Related Wilms Tumor Syndromes, Pancreaticoduodenectomy, and Orchiectomy.

Robert Young is a Neuroradiologist practicing medicine in New York, New York. Dr. Young is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Gliomatosis Cerebri, Meningioma, Pediatric Low-Grade Glioma (pLGG), and ALK-Positive Non-Small Cell Lung Cancer.

Christopher Barker is a Radiation Oncologist practicing medicine in New York, New York. Dr. Barker is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. He is also highly rated in 57 other conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Squamous Cell Skin Carcinoma, Melanoma of the Eye, and Liver Embolization. Dr. Barker is currently accepting new patients.

Gennady Landa is an Ophthalmologist practicing medicine in New York, New York. Dr. Landa is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Retinal Detachment, Diabetic Retinopathy, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Cataract Removal.

Mrinal Gounder is an Oncologist practicing medicine in New York, New York. Dr. Gounder is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Desmoid Tumor, Adult Soft Tissue Sarcoma, Epithelioid Sarcoma, Liposarcoma, and Liver Embolization. Dr. Gounder is currently accepting new patients.

David Della is a General Surgeon practicing medicine in New York, New York. Dr. Della is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Blocked Tear Duct, Entropion, Benign Essential Blepharospasm, and Melanoma of the Eye. Dr. Della is currently accepting new patients.

Emily Tonorezos is an Internal Medicine provider practicing medicine in New York, New York. Dr. Tonorezos is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. Her clinical expertise encompasses Retinoblastoma, Anal Cancer, Acute Lymphoblastic Leukemia (ALL), Splenectomy, and Gallbladder Removal.

Ira Dunkel is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Dunkel is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Retinoblastoma, Diffuse Midline Glioma H3 K27M-Mutant, Brain Stem Cancer, and Glioma. Dr. Dunkel is currently accepting new patients.

Stephen Gilheeney is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Gilheeney is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Medulloblastoma, Sickle Cell Disease, Glioma, and Embryonal Tumor with Multilayered Rosettes.

Matthias Karajannis is an Oncologist practicing medicine in New York, New York. Dr. Karajannis is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Neurofibromatosis, Glioma, Medulloblastoma, and Pineocytoma. Dr. Karajannis is currently accepting new patients.

Sameer Sait is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Sait is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Glioma, Brain Tumor, Medulloblastoma, and Embryonal Tumor with Multilayered Rosettes. Dr. Sait is currently accepting new patients.

Suzanne Wolden is a Pediatric Radiologist practicing medicine in New York, New York. Dr. Wolden is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. She is also highly rated in 54 other conditions, according to our data. Her clinical expertise encompasses Neuroblastoma, Rhabdomyosarcoma, Embryonal Tumor with Multilayered Rosettes, Adult Soft Tissue Sarcoma, and Orchiectomy. Dr. Wolden is currently accepting new patients.

Y Gobin is a Radiologist practicing medicine in New York, New York. Dr. Gobin is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Retinoblastoma, Brain Aneurysm, Hereditary Retinoblastoma, Arteriovenous Malformation, and Thrombectomy.

Anna Escuder is an Ophthalmologist practicing medicine in New York, New York. Dr. Escuder is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Esotropia, Strabismus, Coloboma of Optic Papilla, Coloboma of Optic Nerve, and Tenotomy.

Ekaterina Semenova is an Ophthalmologist practicing medicine in New York, New York. Dr. Semenova is rated as an Advanced provider by MediFind in the treatment of Hereditary Retinoblastoma. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Melanoma of the Eye, Retinoblastoma, Choroid Plexus Carcinoma, Metastatic Uveal Melanoma, and Corneal Transplant. Dr. Semenova is currently accepting new patients.

Lauren Yeager, MD graduated Phi Beta Kappa from the Honors College at the University of Michigan with a degree in Biopsychology and Cognitive Science. She received her medical degree from Boston University School of Medicine and then completed an internal medicine internship at Mount Sinai Hospital in New York, New York. She completed a general ophthalmology residency at State University of New York (SUNY) Downstate Medical Center and then went on to complete a fellowship in pediatric ophthalmology and strabismus at Children’s National Medical Center in Washington, DC. Dr. Yeager specializes in pediatric and adult strabismus, as well as the treatment of all childhood eye conditions. She is fellowship trained to perform a wide variety of pediatric ophthalmic surgeries, including pediatric cataract surgery, anterior segment surgery, lacrimal system surgery, and eyelid surgery. Dr. Yeager is interested in international health care and has participated in multiple medical and surgical mission trips to the Dominican Republic. She has also presented at numerous national meetings, including the Association for Research in Vision and Ophthalmology, the Constenbader Society, and the American Society of Ophthalmic Plastic and Reconstructive Surgery. Dr. Yeager is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Strabismus, Amblyopia, Epicanthal Folds, and Esotropia. Dr. Yeager is board certified in Ophthalmology. Dr. Yeager is currently accepting new patients.